Evidence map›Paper›PMID 31592287›Full record

ArticlePharmacy practice

Role of community pharmacists in skin cancer screening: A descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain.

Joan F Mir, Maria Estrada-Campmany, Anna Heredia, Cristina Rodríguez-Caba, Marta Alcalde, Natalia Espinosa, Jilliana Monnier, Javiera Pérez-Anker, Oriol Yélamos, Susana Puig and 2 more

Abstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Early cancer diagnosis and community pharmacies: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joan F MirConsultant Pharmacist in Research and Projects Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). mir.bonnin@cofb.net.ORCID 0000-0001-8501-0969
Maria Estrada-CampmanyConsultant Pharmacist in Research and Projects Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). mestrada@cofb.net.ORCID 0000-0002-0707-5916
Anna HerediaProfessional Relations Manager. Barcelona Pharmacists Association (COFB). Barcelona (Spain). aheredia@cofb.net.ORCID 0000-0002-0389-4244
Cristina Rodríguez-CabaHead of Department of Continuous Professional Development. Barcelona Pharmacists Association (COFB). Barcelona (Spain). rodriguez.caba@cofb.net.ORCID 0000-0002-5668-6166
Marta AlcaldeCommunity Pharmacist. Dermopharmacy and Medical Devices Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). marta.alcalde@gmail.com.ORCID 0000-0002-6971-1113
Natalia EspinosaDermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). natalia.espinosav08@gmail.com.ORCID 0000-0002-8245-5169
Jilliana MonnierDermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). monnierjilliana@gmail.com.ORCID 0000-0002-8747-5011
Javiera Pérez-AnkerDermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). javiperezanker@gmail.com.ORCID 0000-0002-6959-7250
Oriol YélamosDermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona (Spain). oriol_yelamos@hotmail.com.ORCID 0000-0002-8058-3095
Susana PuigDermatologist. Melanoma Unit, Dermatology Department, IDIBAPS-Hospital Clinic. Barcelona; & Biomedical Research Networking Centers Consortium, Institute of Health Carlos III (CIBER-ISCIII). Barcelona (Spain). susipuig@gmail.com.ORCID 0000-0003-1337-9745
Núria BoschCommunity Pharmacist. Dermopharmacy and Medical Devices Area. Barcelona Pharmacists Association (COFB). Barcelona (Spain). nbosch001@cofb.net.ORCID 0000-0002-9788-6279
Josep MalvehyDermatologist. Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS).Centro de Investigación Biomédica en Red (CIBER), Instituto Carlos III, Barcelona (Spain). jmalvehy@gmail.com.ORCID 0000-0002-6998-914X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkin cancer incidence is increasing alarmingly, despite current efforts trying to improve its early detection. Community pharmacists have proven success in implementing screening protocols for a number of diseases because of their skills and easy access.

objectiveTo evaluate the prevalence of skin cancer risk factors and the photoprotection habits with a questionnaire in community pharmacy users.

methodsA research group consisting of pharmacists and dermatologists conducted a descriptive cross-sectional study to assess photoprotection habits and skin cancer risk factors by using a validated questionnaire in 218 community pharmacies in Barcelona from May 23

resultsA total of 5,530 participants were evaluated. Of those, only 20.2% participants had received a total body skin examination for skin cancer screening in the past by a physician and 57.1% reported using a SPF 50+ sunscreen. 53.9% participants presented ≥1 skin cancer risk factor: 11.8% participants reported having skin cancer familial history and 6.2% reported skin cancer personal history; pharmacists found ≥10 melanocytic nevi in 43.8% participants and chronically sun-damaged skin in 21.4%. Lesions suspicious for melanoma were reported in 10.9% of the participants and urgent dermatological evaluation was recommended.

conclusionsPharmacists can detect people with skin cancer risk factors amongst their users. This intervention can be considered in multidisciplinary strategies of skin cancer screening.

Indexed as

Cross-Sectional StudiesEarly Detection of CancerPharmaciesPharmacistsSkin NeoplasmsSpainSunscreening Agents

Identifiers

PMID31592287
PMCPMC6763307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.